Information and downloads for latest and past shareholder meetings.
The 2020 Annual General Meeting (AGM) is scheduled to take place on Tuesday 26 May at the Queen Elizabeth II Centre (QEII) in London.
Register your proxy and voting instruction at www.investorcentre.co.uk/eproxy
Impact of Covid-19
The Covid-19 pandemic will affect the format of our AGM this year, and our priority is to ensure the health and wellbeing of all stakeholders. In our preparations we will align with government guidance to tackle the spread of the virus, including advice related to public gatherings, whilst continuing to review the most appropriate way to engage with shareholders in the proceedings.
We recognise that the current government guidance prohibits all non-essential travel and the gathering of more than two people from different households (the Stay at Home Measures).?We fully support the Stay at Home Measures, and therefore shareholders must not attend the AGM in person this year?if restrictions on public gatherings remain in force.?The AGM will focus on the formal business of the meeting only.
We recognise that the AGM is valued as an opportunity for shareholders to engage with and hear from the Board and we will do what we can within the confines of the government restrictions to support this principle. Instead of attending in person, shareholders are strongly encouraged to exercise their votes by submitting their proxy electronically or by post. To ensure their vote counts, shareholders should appoint the Chairman of the AGM (and not another named person) as their proxy. In addition, if a shareholder has a question that they would have raised at the meeting, we would ask that the question be submitted by email firstname.lastname@example.org. Full details on registering a proxy or asking a question are available in the Notice of AGM.
We will continue to monitor any changes to government guidance over the coming weeks and will adapt our AGM arrangements accordingly. The Company will communicate any updates to the AGM arrangements on this page. Shareholders are advised to check this page for the most up to date position.
The Board would like to take this opportunity to thank shareholders for their support and understanding in these unprecedented times and wish them well as we all navigate the impact of Covid-19.
On 8 April 2020, we announced that the Board of Directors had agreed to withdraw its recommendation to pay the 2019 final dividend to ordinary shareholders in June 2020. We fully recognise the importance of cash dividends to all of our ordinary shareholders, and expect to reconsider any distributions in the fourth quarter of 2020.
We have taken this decision in the wake of the unprecedented challenges Covid-19 presents for businesses, households and customers, and the adverse and highly uncertain impact on the global economy. Regulatory authorities, including EIOPA, the PRA and supervisors of other Aviva subsidiaries, have responded by publicly urging restraint on dividend payments by insurers to shareholders. In light of the significant uncertainties presented by Covid-19, we agree with our regulators that it is prudent to suspend dividend payments on our ordinary shares. We intend to provide an operational update for investors in the second half of May.
Due to the timing of this announcement, the Form of Proxy sent to shareholders includes the approval of a final dividend as resolution 3. This resolution has been withdrawn and any votes received in respect of this resolution will not be counted.